Glaxo Lotronex Formulary Kit Faulted For Implied Claims Beyond Studies
Executive Summary
Glaxo Wellcome Lotronex marketing materials "contain unsubstantiated Health-Related Quality of Life, productivity and economic claims" not adequately supported by clinical studies, FDA charged in an April 28 letter from the agency's Division of Drug Marketing, Advertising & Communications.